| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.125 | 4.643 | 2.203 | 0 | 0 | 101 | 0 | 27.641 | 30.164 |
| Total Income - EUR | - | 3.125 | 4.643 | 2.203 | 0 | 0 | 101 | 0 | 27.641 | 30.164 |
| Total Expenses - EUR | - | 1.203 | 1.330 | 1.366 | 185 | 0 | 0 | 107 | 12.453 | 14.433 |
| Gross Profit/Loss - EUR | - | 1.922 | 3.314 | 837 | -185 | 0 | 101 | -107 | 15.187 | 15.731 |
| Net Profit/Loss - EUR | - | 1.829 | 3.174 | 771 | -185 | 0 | 98 | -107 | 14.911 | 14.823 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Centrul De Excelenţă În Diabet Şi Nutriţie Aramed
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 1.948 | 5.070 | 5.614 | 0 | 0 | 0 | 0 | 16.060 | 16.462 |
| Inventories | - | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92 |
| Receivables | - | 276 | 488 | 0 | 0 | 0 | 0 | 0 | 4.393 | 1.430 |
| Cash | - | 1.654 | 4.582 | 5.614 | 0 | 0 | 0 | 0 | 11.667 | 14.940 |
| Shareholders Funds | - | 1.873 | 3.227 | 822 | -134 | -132 | -31 | -138 | 14.773 | 14.871 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 75 | 1.843 | 4.791 | 134 | 132 | 31 | 138 | 1.287 | 1.591 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Centrul De Excelenţă În Diabet Şi Nutriţie Aramed S.r.l.